Alamar Biosciences, Inc.
NASDAQ:ALMRBiotechnology
+$1.11 today
- Market cap
- $2.12B
- Beta
- 0.00
- P/E (TTM)
- -47.5
- EPS (TTM)
- -$0.45
Volume 0.53M
Average 0.38M
ALMR Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Alamar Biosciences, Inc.NASDAQ: ALMR
Gross Margin · Q2 FY2026 · quarter ended Jun 2026
Gross margin at 60.2%
Gross margin was 60.2% in Q2 FY2026.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 56.2%
- Year-over-year change
- —
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 56.2% | — |
Gross Margin vs competitors
How ALMR compares with its peers on the latest reported figures
- ALMR's FY2025 gross margin of 56.2% is the 3rd highest of the 8 companies compared; the peer median is 48.3%.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 71.9% | +3.0 pp | -7.6 pp | |
| LTM Sep 2026 | 65.8% | +0.4 pp | -2.0 pp | |
ALMRAlamar Biosciences, Inc. | FY2025 | 56.2% | — | — |
| LTM Sep 2026 | 52.4% | +1.7 pp | +15.8 pp | |
| LTM Mar 2026 | 48.3% | -1.2 pp | +12.0 pp | |
| LTM Mar 2026 | 48.3% | +18.6 pp | +9.2 pp | |
| LTM Mar 2026 | 40.0% | -12.8 pp | — | |
| LTM Mar 2026 | 37.1% | +20.9 pp | -6.5 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding ALMR) | 48.3% | +1.7 pp | +3.6 pp | |
Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 74.21M |
| Cost of Revenue | 32.51M |
| Gross Profit | 41.71M |
| Gross Margin | 56.2% |
| Research & Development | 37.47M |
| Selling, General & Admin | 35.57M |
| Operating Expenses | 73.04M |
| Depreciation & Amortization | 3.86M |
| EBITDA | (24.89M) |
| EBITDA Margin | -33.5% |
| Operating Income | (31.33M) |
| Operating Margin | -42.2% |
| Interest Income | 2.16M |
| Interest Expense | 401K |
| Other Income / Expenses | 2.18M |
| Income Before Tax | (29.15M) |
| Pre-Tax Margin | -39.3% |
| Income Tax Expense | 665K |
| Net Income | (29.82M) |
| Net Margin | -40.2% |
| EPS (Basic) | (0.45) |
| EPS (Diluted) | (0.45) |
| Weighted Avg Shares | 66.52M |
| Weighted Avg Shares (Diluted) | 66.52M |
Alamar Biosciences, Inc.
NASDAQ:ALMR
Intrinsic Alpha fair value
Locked
Current Price
$30.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.